The present invention relates to biaryl derivatives of Formula 1, a method for preparing the same, a pharmaceutical composition comprising the same and use thereof The biaryl derivatives of Formula 1 according to the present invention promote GLP-1 formation in the gastrointestinal tract and improve insulin resistance in the liver or in muscle due to anti-inflammatory action in macrophages, lipocytes, etc., and can accordingly be effectively used for preventing or treating diabetes, complications of diabetes, obesity, non-alcoholic fatty liver, steatohepatitis, osteoporosis or inflammation.wherein, A, B, D, E, G, R<；sub>；1<；/sub>；, R<；sub>；2<；/sub>；, R<；sub>；3<；/sub>；, R<；sub>；4<；/sub>；, R<；sub>；7<；/sub>；, m and n are as defined herein.
